- Home
- HERE vs SLGL Comparison
HERE vs SLGL Comparison
Compare HERE & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.07
HOLD
Current Price
$68.22
Company Overview
Basic Information| Metric | HERE | SLGL |
|---|---|---|
| Founded | 2019 | 1997 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.4M | 247.1M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | HERE | SLGL |
|---|---|---|
| Price | $3.07 | $68.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $110.00 |
| AVG Volume (30 Days) | ★ 117.3K | 10.5K |
| Earning Date | 03-12-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $44.25 | $223.84 |
| P/E Ratio | $2.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.15 | $0.40 |
| 52 Week High | $5.80 | $97.97 |
Technical Indicators
Market Signals| Indicator | HERE | SLGL |
|---|---|---|
| Relative Strength Index (RSI) | 25.45 | 41.76 |
| Support Level | N/A | $32.56 |
| Resistance Level | $4.71 | $71.43 |
| Average True Range (ATR) | 0.25 | 11.12 |
| MACD | -0.11 | -2.76 |
| Stochastic Oscillator | 6.13 | 17.76 |
Price Performance
Historical Comparison HERE
SLGL
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.